In addition, Random Forest Analysis also implicated DC-SIGNR, adiponectin, GRN, and MMP-12 as additional discriminatory molecules with the largest impact on IBD versus healthy control discrimination (Fig. 2d). This evidence concerns the gene ADIPOQ and irritable bowel syndrome.